{
    "body": "What is the percentage of responders to tetrabenazine treatment for dystonia in children?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19808991", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9040721", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12710012", 
        "http://www.ncbi.nlm.nih.gov/pubmed/6128697", 
        "http://www.ncbi.nlm.nih.gov/pubmed/3400500", 
        "http://www.ncbi.nlm.nih.gov/pubmed/6502174", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9549503", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18555882", 
        "http://www.ncbi.nlm.nih.gov/pubmed/2904118", 
        "http://www.ncbi.nlm.nih.gov/pubmed/6889706", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22515742"
    ], 
    "ideal_answer": [
        "Tetrabenazine is used empirically in the treatment of dystonia in children with variable success. Observational studies report improvement of up to > 60% of the patients."
    ], 
    "exact_answer": [
        "up to > 60%"
    ], 
    "concepts": [
        "http://www.disease-ontology.org/api/metadata/DOID:543", 
        "http://www.disease-ontology.org/api/metadata/DOID:544", 
        "http://www.disease-ontology.org/api/metadata/DOID:5159", 
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014103", 
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013747", 
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004421", 
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020821", 
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009069"
    ], 
    "type": "factoid", 
    "id": "515ddda6298dcd4e5100001f", 
    "snippets": [
        {
            "offsetInBeginSection": 12, 
            "offsetInEndSection": 94, 
            "text": "report a patient with dystonia secondary to bilateral lesions of the basal ganglia", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19808991", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 494, 
            "offsetInEndSection": 635, 
            "text": "The patient's dystonia responded to Trihexyphenidyl and to tetrabenazine, but these medications needed to be stopped because of side effects.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19808991", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 239, 
            "offsetInEndSection": 375, 
            "text": "An 8-year-old girl received 53 grays radiotherapy after surgery for craniopharyngioma. One year later she developed generalized dystonia", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18555882", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 481, 
            "offsetInEndSection": 606, 
            "text": "Pharmacological treatment with tetrabenazine, clonazepam and trihexiphenydile allowed a very limited improvement of dystonia;", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18555882", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 167, 
            "offsetInEndSection": 249, 
            "text": "welve cases of status dystonicus, of various underlying aetiologies, are presented", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9549503", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1134, 
            "offsetInEndSection": 1237, 
            "text": "Drug therapy with benzhexol, tetrabenazine and pimozide or haloperidol may be beneficial in some cases.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9549503", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 120, 
            "text": "Over the past 15 years we have treated 526 patients with severe hyperkinetic movement disorders with tetrabenazine (TBZ)", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9040721", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 502, 
            "offsetInEndSection": 799, 
            "text": "The global response rating of 1 (marked improvement) was recorded in 89.2% of 93 patients with tardive stereotypy, 83.3% of 12 with myoclonus, 82.8% of 29 with Huntington's disease, 80.5% of 82 with tardive dystonia, 79.3% of 29 with other movement disorders, 62.9% of 108 with idiopathic dystonia", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9040721", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 462, 
            "offsetInEndSection": 692, 
            "text": "Twelve adults with severe axial dystonia, and two children with life-threatening generalised dystonia were treated with a combination of a low constant dose of tetrabenazine to which were added pimozide and benzhexol as necessary.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/6502174", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1341, 
            "offsetInEndSection": 1582, 
            "text": "When benzhexol treatment alone fails in adults with severe disabling axial dystonia, or in children with life-threatening generalised dystonia, combined therapy with tetrabenazine, pimozide and benzhexol may give valuable symptomatic relief.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/6502174", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 330, 
            "offsetInEndSection": 424, 
            "text": "We present 42 patients with tardive dystonia. The age of onset of dystonia was 13 to 60 years.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/6128697", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 682, 
            "offsetInEndSection": 804, 
            "text": "The most frequently helpful medications were tetrabenazine (68% of patients improved) and anticholinergics (39% improved).", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/6128697", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 151, 
            "offsetInEndSection": 373, 
            "text": "8-year-old boy of non-Jewish, Mexican-American descent with autosomal-dominant dystonia musculorum deformans who developed rapidly progressive and severe generalized dystonia, hyperpyrexia, myoglobinuria, and renal failure", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/6889706", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 402, 
            "offsetInEndSection": 468, 
            "text": "Transient improvement was achieved with tetrabenazine and baclofen", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/6889706", 
            "endSection": "sections.0"
        }
    ]
}